Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Pandoraon Nov 27, 2021 12:24pm
223 Views
Post# 34172213

RE:RE:RE:Timing

RE:RE:RE:Timing
menoalittle wrote: >> ...we are not focusing on the virus, but on the host cell. 

Thanks for putting that back in front of us, Pandora.  Looks to me like they are focused on keeping host cells healthy not by prevention (blocking or handcuffing viruses - which have this incredible ability to eventually mutate and overcome), but by treatment (post infection) that is first and foremost safe to the host cell, but is also highly effective at killing any sort of virus that invades.  Sound a bit similar to their approach to cancer?

But, if there's any doubt that they're focused on a treatment rather than a prevention, then look again at what was said at the end of that quote:

>> ...
there is a need to use multiple approaches to obtain a highly efficient treatment.


(A side point here - once a treatment is known and acknowledged as being effective against something, the FDA's "emergency use" is no longer applicable.) 


And the profound need for that highly efficient treatment has been left on the back burner for 18 months, regardless of "warp speed", and their primary objective of selling vaccines. Meanwhile the daily chart of 'covid deaths' continues on.
<< Previous
Bullboard Posts
Next >>